Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

A case of slowly progressive type 1 diabetes with insulin independence maintained for 10 years with α-glucosidase inhibitor monotherapy.

Munakata Y, Yamada T, Takahashi K, Tsukita S, Takahashi K, Sawada S, Imai J, Ishigaki Y, Oka Y, Katagiri H.

Intern Med. 2012;51(24):3391-4.

2.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
3.

[Effects of acarbose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].

Sakamoto N, Tajima N.

Nihon Rinsho. 2005 Feb;63 Suppl 2:451-6. Review. Japanese. No abstract available.

PMID:
15779421
4.

alpha-Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects.

Toeller M.

Eur J Clin Invest. 1994 Aug;24 Suppl 3:31-5. Review.

PMID:
8001625
5.

Acarbose and insulin therapy in type I diabetes mellitus.

Rios MS.

Eur J Clin Invest. 1994 Aug;24 Suppl 3:36-9. Review.

PMID:
8001626
6.

[Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus].

Fölsch UR, Lembcke B.

Internist (Berl). 1991 Dec;32(12):699-707. Review. German. No abstract available.

PMID:
1823561
7.

Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes.

Welborn TA.

Med J Aust. 1998 Jan 19;168(2):76-8. Review. No abstract available.

PMID:
9469188
8.

Who should benefit from the use of alpha-glucosidase inhibitors?

Godbout A, Chiasson JL.

Curr Diab Rep. 2007 Oct;7(5):333-9. Review.

PMID:
18173965
9.

The evolving role of alpha-glucosidase inhibitors.

Göke B, Herrmann-Rinke C.

Diabetes Metab Rev. 1998 Sep;14 Suppl 1:S31-8. Review. No abstract available.

PMID:
9816485
10.

Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers.

Raptis SA, Dimitriadis GD.

Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S265-87. Review.

PMID:
11460577
11.

Acarbose: an alpha-glucosidase inhibitor.

Martin AE, Montgomery PA.

Am J Health Syst Pharm. 1996 Oct 1;53(19):2277-90; quiz 2336-7. Review.

PMID:
8893066
12.

Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus.

Kobayashi T, Maruyama T, Shimada A, Kasuga A, Kanatsuka A, Takei I, Tanaka S, Yokoyama J.

Ann N Y Acad Sci. 2002 Apr;958:117-30. Review.

PMID:
12021091
13.

[Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].

Calsolari MR, Rosário PW, Reis JS, Silva SC, Purisch S.

Arq Bras Endocrinol Metabol. 2008 Mar;52(2):315-21. Review. Portuguese.

14.

The use of acarbose in the prevention and treatment of hypoglycaemia.

Lefebvre PJ, Scheen AJ.

Eur J Clin Invest. 1994 Aug;24 Suppl 3:40-4. Review.

PMID:
8001627
15.
16.
17.

The mechanism of alpha-glucosidase inhibition in the management of diabetes.

Bischoff H.

Clin Invest Med. 1995 Aug;18(4):303-11. Review.

PMID:
8549017
18.

[alpha-Glucosidase inhibitor].

Ishida H.

Nihon Rinsho. 1999 Mar;57(3):669-74. Review. Japanese.

PMID:
10199152
19.

[alpha-Glucosidase inhibitors in the therapy of diabetes mellitus].

Giorgino R, Damato A.

Ann Ital Med Int. 1995 Oct;10 Suppl:61S-65S. Review. Italian.

PMID:
8562269
20.

[Alpha glucosidase inhibitor].

Katsuta H, Ishida H.

Nihon Rinsho. 2006 Dec 28;64 Suppl 9:637-45. Review. Japanese. No abstract available.

PMID:
17458296
Items per page

Supplemental Content

Support Center